Transgene SA Product Pipeline Review - 2015
Published on : October - 2015
.
Report Overview About Transgene SA - Product Pipeline Review - 2015 Research Beam added report on “Transgene SA Product Pipeline Review - 2015�. Summary Global Markets Directs, Transgene SA Product Pipeline Review - 2015, provides an overview of the
Transgene SA s Transgene SA research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Transgene SA s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also
reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
Get Full Details On : http://www.researchbeam.com/transgene-sa-product-pipeline-review-2015-
market
.
Report Overview Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance
of data for the indicated disease.
.
Report Overview Scope The report provides brief overview of Transgene SA including business description, key information and
facts, and its locations and subsidiaries The report reviews current pipeline of Transgene SA s human therapeutic division and enlists all their major and minor projects The report features product description and descriptive mechanism of action for key pipeline products
along with the products developmental history and major milestones Special feature on out-licensed and partnered product portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement
Latest news and deals relating to the Transgene SA s pipeline products
Report Overview Reasons to buy Evaluate Transgene SA s strategic position with total access to detailed information on its product pipeline Assess the growth potential of Transgene SA in its therapy areas of focus
Identify new drug targets and therapeutic classes in the Transgene SA s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps Develop strategic initiatives by understanding the focus areas of Transgene SA and exploit
collaboration and partnership opportunities Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage Plan mergers and acquisitions effectively by identifying the most promising pipeline of Transgene SA
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope Explore the dormant and discontinued projects of Transgene SA and identify potential opportunities in those areas
Table Of Contents Table of Contents 2 List of Tables 6 List of Figures 6 Transgene SA Snapshot 7
Transgene SA Overview 7 Key Information 7 Key Facts 7 Transgene SA - Research and Development Overview 8
Key Therapeutic Areas 8 Transgene SA - Pipeline Review 11 Pipeline Products by Stage of Development 11 Pipeline Products - Monotherapy 12 Pipeline Products - Combination Treatment Modalities 13 Pipeline Products - Partnered Products 14
Table Of Contents Partnered Products/Combination Treatment Modalities 15 Pipeline Products - Out-Licensed Products 16 Out-Licensed Products/Combination Treatment Modalities 17
Transgene SA - Pipeline Products Glance 18 Transgene SA - Late Stage Pipeline Products 18 Partnered Products/Combination Treatment Modalities 15 Pipeline Products - Out-Licensed Products 16
Out-Licensed Products/Combination Treatment Modalities 17 Transgene SA - Pipeline Products Glance 18 Transgene SA - Late Stage Pipeline Products 18
Table Of Contents Pre-Registration Products/Combination Treatment Modalities 18 Filing rejected/Withdrawn Products/Combination Treatment Modalities 19 Phase III Products/Combination Treatment Modalities 20 Transgene SA - Clinical Stage Pipeline Products 21 Phase II Products/Combination Treatment Modalities 21 Phase I Products/Combination Treatment Modalities 22 Transgene SA - Early Stage Pipeline Products 23 Preclinical Products/Combination Treatment Modalities 23 Discovery Products/Combination Treatment Modalities 24
Enquiry about this report @ http://www.researchbeam.com/transgene-sa-product-pipelinereview-2015-market/enquire-about-report
FOR MORE DETAILS Visit us at : http://www.researchbeam.com/transgene-sa-productpipeline-review-2015-market
Stay With Us:
TELEPHONE: +1 (800) 910-6452 E-MAIL: sales@researchbeam.com
5933 NE Win Sivers Drive, #205, Portland, OR 97220 United States